|Vaso Corporation -- USA Stock|| |
USD 0.08 0.01 14.29%
CEO and President and Director
Dr. Jun Ma, Ph.D., is President, Chief Executive Officer, Director of the Company. He was a director since June 2007 and was appointed President and Chief Executive Officer of the Company on October 16, 2008. Dr. Ma has held various positions in academia and business, and prior to becoming President and CEO of the Company, had provided technology and business consulting services to several domestic and international companies in aerospace, automotive, biomedical, medical device, and other industries, including Kerns Manufacturing Corporationration and Living Data Technology Corporationration, both of which are stockholders of our Company
Age: 52 CEO Since 2010
Ma received his PhD degree in mechanical engineering from Columbia University, MS degree in biomedical engineering from Shanghai University, and BS degree in precision machinery and instrumentation from University of Science and Technology of China.
The company has return on total asset (ROA)
of (1.7) %
which means that it has lost $1.7 on every $100 spent on asset. This is way below average. Similarly, it shows return on stockholders equity (ROE)
of (21.69) %
meaning that it created substantial loss on money invested by shareholders.
The company currently holds 9.23 M in liabilities with Debt to Equity (D/E) ratio of 90.5 indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Vaso Corporation has Current Ratio of 0.79 indicating that it has a negative working capital and may not be able to pay financial obligations when they are due.
Vasomedical, Inc. operates in the healthcare equipment and information technology industries. Vaso Corporation (VASO) is traded on OTC Market in USA. It is located in NEW YORK, U.S.A and employs 281 people. Vaso is listed under Medical Equipment category by Fama And French industry classification.